Skip to content
AdAdvertisement
Value Science Weekly — health economics and market access, in your inbox

Syenza News — health technology assessment, market access and health economics

Syenza's Top Picks

Latest News

Hospital day room with a wide window overlooking a garden with flowering trees

Clinical Practice

EMA Recommends Gazyvaro for Systemic Lupus Erythematosus: What the Trial Shows

EMA recommends Gazyvaro for systemic lupus erythematosus after a 303-patient trial showed 76.7% response on add-on therapy versus 53.5% on placebo.

Syenza TeamRead ›
Nurse and researcher talking at a table by a window over a city at dusk

Artificial Intelligence And Machine Learning

Learning Health System Frameworks and AI in US Care: A Scoping Review

A scoping review of 54 learning health system framework studies and 31 AI studies in US care finds that AI work mostly stops at turning data into knowledge. Only three AI studies reached practice, and none described feedback from deployment back into the model. #SyenzaNews #MarketAccess

Syenza TeamRead ›
capsule sponge tests for oesophageal cancer

Clinical Practice

NICE Draft Guidance Backs Capsule Sponge Tests for Oesophageal Cancer

NICE draft guidance recommends Cytosponge and EndoSign to help detect oesophageal cancer and Barrett’s oesophagus. The tests need no sedation and can be done outside hospital. #SyenzaNews #MarketAccess #HealthTech

Syenza TeamRead ›
Canal-side street in a northern European city with a stone bridge, cyclists and a glass office building

Cardiovascular And Metabolic Diseases

CHMP November 2026 Recommends Seven New Medicines for Approval

EMA’s CHMP recommended seven new medicines and 11 indication extensions at its 9 to 12 November 2026 meeting, and confirmed two refusals after re-examination.

Syenza TeamRead ›
Pharmacy counter with a dish of white tablets and a glass of water beside a window onto a town street

Cardiovascular And Metabolic Diseases

Baxfendy EU Positive Opinion: CHMP Backs AstraZeneca’s Hypertension Tablet

The CHMP recommended granting a marketing authorisation for AstraZeneca’s Baxfendy (baxdrostat) for insufficiently controlled hypertension. The European Commission makes the final decision. #SyenzaNews #MarketAccess

Syenza TeamRead ›
NHLS Governance Crisis Reaches Parliament With R1.8 Billion in Irregular Spending

Healthcare Spending Free account

NHLS Governance Crisis Reaches Parliament With R1.8 Billion in Irregular Spending

The NHLS governance crisis reached Parliament with R1.8 billion in irregular spending, an interim board and a disputed IP Capital consultancy.

Syenza TeamRead ›
Two brass balance scales on a wooden table beside a stethoscope

Clinical Guidelines And Protocols

Appropriate Comparator Use for EMA-Approved Drugs Fell From 2011 to 2024

Only 58% of EMA-approved drug indications from 2011 to 2024 had at least one trial population tested against an appropriate comparator. The share fell from 78% of 2011 to 2012 approvals to 39% of 2023 to 2024 approvals. #SyenzaNews #MarketAccess

Syenza TeamRead ›
prostate cancer screening guideline

Clinical Guidelines And Protocols

ACS Updates Prostate Cancer Screening Guideline for PSA Testing

“The American Cancer Society has updated its prostate cancer screening guideline, with regular PSA testing for average-risk men aged 50 to 69.” #SyenzaNews #ProstateCancer

Syenza TeamRead ›
SADC pharmaceutical pooled procurement

Health Policy

SADC Pharmaceutical Pooled Procurement Charter Signed in Durban

The Charter establishing the SADC Pharmaceuticals Pooled Procurement Services was signed in Durban on 12 November 2026, with Tanzania the first Member State to sign. #SyenzaNews #MarketAccess

Syenza TeamRead ›
Clean laboratory workbench with glass vials and a pharmacist in a white coat

Clinical Practice

Aspen Gets Approval for Generic Semaglutide in Brazil and South Africa

Aspen Pharmacare has received approval for generic semaglutide in Brazil and South Africa, following Canada in July. Launches in all three markets are expected over the coming months. #SyenzaNews #MarketAccess

Syenza TeamRead ›

Value Science Weekly

The week in health technology assessment, market access and health economics — what moved, and what it means.

You can unsubscribe at any time. Read our privacy policy.

About this newsletter →

Search Intelligence